Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

NASDAQ:ESRX

Express Scripts Inc (ESRX)

92.48
-0.00 (0.00%)
as of Dec 20, 2018, 8:59:59 pm Market Open.
5 watching
0
BUY ON WEAKNESS

They are positioned well for growth under the affordable care act. There has been a lot of spending on systems in advance and this could hamper the earnings in the short term. He would wait and buy on weakness.

DON'T BUY

The downward price gap is a trend reversal to down. You’d have to get to the $60 level to start filling the gap. That would be confirmation of a reversal. Momentum is declining. If it breaks below $50 then it will go to $46-$47.

TRADE
Rumor today that Express Scripts and Walgreen have come to an agreement. In pharmacy space likes Walgreen over Express Scripts.
SELL
A number of things going on in their business. Outlook for Pharmacies Benefit Management for the next several years is not good. Wal-Mart is creating competition in dispensing of prescriptions.
TOP PICK
Healthcare is a budding sector right now. Very reasonably valued. Significant increase in analysts estimates going into the quarter.
Showing 16 to 20 of 20 entries